Company data from Slovak public registers

Andromia Insight
Terminated since Saturday, October 31, 2015

Pharm. Dr. Anton Korec Lekáreň VERBENA

Company financial profile・Company ID 34002847・Kuzmányho 1608, 95501 Topoľčany・Founded 1997

Financial reportFinancial statements

Profit

—

The company has not published financial data.

Company ID
34002847
Tax ID
—
VAT ID
—
Registered office
Pharm. Dr. Anton Korec Lekáreň VERBENAKuzmányho 1608 95501 Topoľčany
Established
Monday, May 26, 1997
Legal form
Podnikateľ-fyzická osoba-nezapísaný v obchodnom registri
Registered in
Živnostenský registerOkresný úrad Topoľčany, 406-7221
Dissolution date
Saturday, October 31, 2015

Company reliability

  • The entity is listed as an unreliable VAT payerNo
  • Former unreliable VAT payerNo
  • Excess VAT deductionNo
  • Tax reliability indexNot stated
  • Tax debtNo
  • Debt with VšZPNo
  • Debt with UnionNo
  • Debt with Social Insurance AgencyNo

Business activities

4 registered activities

  • Maloobchod so zmiešaným tovarom mimo prevádzkyValid Monday, May 26, 1997 – Saturday, October 31, 2015
  • Maloobchod so zmiešaným tovarom v rozsahu voľnej živnostiValid Monday, May 26, 1997 – Saturday, October 31, 2015
  • Sprostredkovanie obchodu a služiebValid Monday, May 26, 1997 – Saturday, October 31, 2015
  • Veľkoobchod so zmiešaným tovarom v rozsahu voľnej živnostiValid Monday, May 26, 1997 – Saturday, October 31, 2015

Statutory bodies and related persons

Statutory body

0 active of 1
  • Pharm.Dr. Anton KorecBirth surname: KorecInactive
    PodnikateľMonday, May 26, 1997 – Saturday, October 31, 2015

    Address Kuzmányho 1608, 95501 Topoľčany, Slovenská republika

Related persons

No related persons are recorded.

Registration

Registered in Živnostenský register

Register
Živnostenský register
Registration court
Okresný úrad Topoľčany
Registration number
406-7221
Pharm. Dr. Anton Korec Lekáreň VERBENA

Registered office

Pharm. Dr. Anton Korec Lekáreň VERBENA

Kuzmányho 1608, 95501 Topoľčany

Open in Google Maps

Start monitoring the market today

Contact us and get platform access. No commitment.

Contact us